BRIEF-Bioverativ says on June 28, entered into a credit agreement
* Bioverativ inc - on june 28, entered into a credit agreement by and among bioverativ and certain subsidiaries as borrowers - sec filing
April 25 Com Hem
* Q1 revenue saw a increase of 37.7% to SEK 1,757m while organic revenue rose by 3.5% to SEK 1,321m.
* Q1 Operating profit (EBIT) rose by 13.1% to SEK 232m. Further company coverage: (Reporting By Johan Ahlander)
* Navidea biopharmaceuticals inc - on june 26, co and fti consulting entered into a settlement agreement - sec filing